Artia Global Partners »

Pepgen shares owned by Artia Global Partners

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 205k 6.51

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Pepgen

RA Capital Management
Viking Global Investors
Commodore Capital
Vivo Capital
Point72 Asset Management
Vanguard Group
Laurion Capital Management
BVF
Nantahala Capital Management
Henderson Group
Adage Capital Partners GP
Pictet Asset Management Holding SA
Balyasny Asset Management
Woodline Partners
AWM Investment Company

View all funds holding Pepgen